Structural interventions to reduce HIV transmission among injecting drug users

被引:115
作者
Des Jarlais, DC [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Inst Chem Dependency, New York, NY 10003 USA
关键词
substance abuse; drug use; HIV; AIDS; prevention; structural intervention; policy;
D O I
10.1097/00002030-200006001-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To review current knowledge of 'structural' interventions to reduce HIV transmission among injecting drug users. Structural interventions are defined as programs or policies that change the environments in which risk behavior occurs, without attempting to change knowledge, attitudes or social interaction patterns of the persons at risk. Structural interventions may either facilitate enactment of existing motives to avoid HIV transmission or make enacting risk behavior more difficult. Methods: Nonquantitative literature review. Results and conclusions: Preventing HIV infection among injecting drug users must be considered within the context of the continuing global spread of psychoactive drug use, and injecting drug use in particular. Some policies that are designed to reduce drug use may tend to increase HIV transmission among persons who do inject drugs. Evaluation of-structural interventions can be difficult, as populations of drug users are usually the relevant unit of analysis. Typically, pre versus post comparisons must be used, hopefully with multiple pre and post data points. Structural interventions are often associated with 'large effects', increasing confidence that the intervention is the cause of the reduction in HIV-risk behavior. Increasing the availability of sterile injection equipment, through pharmacy sales or syringe exchange or both, is the most common and best-studied structural intervention for injecting drug users. The studies to date indicate that this usually, but not always, leads to large reductions in HIV-risk behavior. Involving drug users in the design and implementation of HIV-prevention programs can be considered a 'meta-structural' intervention that should lead to programs with increased effectiveness. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:S41 / S46
页数:6
相关论文
共 50 条
[41]   Network Structure and the Risk for HIV Transmission Among Rural Drug Users [J].
Young, A. M. ;
Jonas, A. B. ;
Mullins, U. L. ;
Halgin, D. S. ;
Havens, J. R. .
AIDS AND BEHAVIOR, 2013, 17 (07) :2341-2351
[42]   HIV and Injecting Drug Users in Vietnam: An Overview of Policies and Responses [J].
Ahmed, Tanvir ;
Nguyen Thanh Long ;
Phan Thi Thu Huong ;
Stewart, Donald Edwin .
WORLD MEDICAL & HEALTH POLICY, 2014, 6 (04) :395-418
[43]   Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City [J].
Des Jarlais, Don C. ;
Arasteh, Kamyar ;
Perlis, Theresa ;
Hagan, Holly ;
Abdul-Quader, Abu ;
Heckathorn, Douglas D. ;
McKnight, Courtney ;
Bramson, Heidi ;
Nemeth, Chris ;
Torian, Lucia V. ;
Friedman, Samuel R. .
AIDS, 2007, 21 (02) :231-235
[44]   Seroprevalence and Correlates of HIV and HCV among Injecting Drug Users in Edmonton, Alberta [J].
Plitt, Sabrina S. ;
Gratrix, Jennifer ;
Hewitt, Sharyn ;
Conroy, Patsy ;
Parnell, Tracy ;
Lucki, Beverly ;
Pilling, Vicki ;
Anderson, Barbara ;
Choudri, Yogesh ;
Archibald, Chris P. ;
Singh, Ameeta E. .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2010, 101 (01) :50-55
[45]   Seroprevalence and Correlates of HIV and HCV among Injecting Drug Users in Edmonton, Alberta [J].
Sabrina S. Plitt ;
Jennifer Gratrix ;
Sharyn Hewitt ;
Patsy Conroy ;
Tracy Parnell ;
Beverly Lucki ;
Vicki Pilling ;
Barbara Anderson ;
Yogesh Choudri ;
Chris P. Archibald ;
Ameeta E. Singh .
Canadian Journal of Public Health, 2010, 101 :50-55
[46]   Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia [J].
Abel-Ollo, K. ;
Rahu, M. ;
Rajaleid, K. ;
Talu, A. ;
Rueuetel, K. ;
Platt, L. ;
Bobrova, N. ;
Rhodes, T. ;
Uuskuela, A. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (07) :851-857
[47]   Measuring risk of HIV and HCV among injecting drug users in the Russian Federation [J].
Platt, Lucy ;
Sutton, A. J. ;
Vickerman, P. ;
Koshkina, E. ;
Maximova, S. ;
Latishevskaya, N. ;
Hickman, M. ;
Bonell, C. ;
Parry, J. ;
Rhodes, T. .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2009, 19 (04) :428-433
[48]   Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users [J].
Alexander, CS ;
Dong, W ;
Schechter, MT ;
O'Shaughnessy, MV ;
Strathdee, SA ;
Mo, T ;
Montaner, JSG ;
Harrigan, PR .
AIDS, 1999, 13 (08) :981-985
[49]   HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years [J].
Hope, VD ;
Judd, A ;
Hickman, M ;
Sutton, A ;
Stimson, GV ;
Parry, JV ;
Gill, ON .
AIDS, 2005, 19 (11) :1207-1214
[50]   HIV Heterosexual Sexual Risk From Injecting Drug Users Among HIV-Seronegative Noninjecting Heroin Users [J].
Neaigus, Alan ;
Miller, Maureen ;
Gyarmathy, V. Anna ;
Friedman, Samuel R. .
SUBSTANCE USE & MISUSE, 2011, 46 (2-3) :208-217